Remove Laboratories Remove Pharma Companies Remove Therapies
article thumbnail

Best CDMO Practices for Startups: Navigating the Complex World of Contract Development and Manufacturing

Drug Patent Watch

Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation.

article thumbnail

Drug Repurposing: A New Life for Old Drugs

DrugBank

Drug repurposing’s potential to target undruggable molecules is showing huge promise for its ability to accelerate the development of new therapies and improve patient outcomes. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 71
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to find a drug: the past, present and future of small molecule drug discovery?

DrugBaron

Despite the current hype around so called “advanced therapies”, which range from gene editing to cell therapies, and the inexorable advance of biologic therapeutics such as monoclonal antibodies, even in 2022 the majority of drugs in development and reaching patients are still small organic molecules.

article thumbnail

What is the largest CRO in the US?

Vial

billion in 2023 attributable to its laboratory products and biopharma services segment (53.8% By type of service, clinical research services accounted for the lion’s share of the North American CRO services market, followed by early-phase development services, laboratory services, and consulting services. of total revenue).

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Goater is CEO at Surface Oncology, an immuno-oncology company developing next-generation antibody therapies. TISSIUM – France’s TISSIUM announced Michel Thérin has been appointed to the company ’ s board of directors. Thérin is the president of Advanced Therapies at Siemens Healthineers. Immune Regulation – U.K.-based

article thumbnail

Predictive Oncology looks to improve precision cancer Rx development with AI-driven platform

Predictive Oncology

With its technology, the company wants to change the way that biopharma companies plan clinical trials and develop oncology drugs. This is all about getting the right drugs to the right patients at the right time as soon as possible to personalize the treatment of their therapies, primarily in oncology,” said Vennare.

article thumbnail

Algae: a source for prebiotics and drugs to treat IBD

Drug Target Review

Therapies developed in recent decades have transformed the treatment of IBD, making hospitalisation and surgery less common. However, many patients respond poorly to corticosteroid treatment, or their immune system responds unfavourably to biological therapies, such as the development of autoimmune diseases.

Drugs 75